Grindeks (GRD1R):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Grindeks (GRD1R) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10146
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ラトビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Grindeks focuses on the research, development, manufacture and marketing of novel pharmaceuticals, generic products and active pharmaceutical ingredients (APIs). Its products are indicated for treating diseases in cardiovascular, central nervous system (CNS) and cancer therapeutic categories. The company provides final dosage form pharmaceutical products ranging from solid form products, solution for injections to syrups and ointments. Grindeks also provides regulatory, analytical and final dosage form contract manufacturing services to pharmaceutical companies. Through subsidiaries and representative offices, the company markets its products in the European (EU) countries, the US, Canada, Russia and other CIS countries, Japan and Vietnam. Grindeks operates subsidiary companies in Latvia, Estonia, Russia and Slovakia and is headquartered in Riga, Latvia.

Grindeks (GRD1R) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Grindeks, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Grindeks, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Grindeks, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Grindeks, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Grindeks, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Grindeks, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
AB.LV Private Equity Fund Acquires Stake In Grindeks From East Capital 10
Partnerships 11
Riga Stradins University to Enter into Agreement with Grindeks 11
Acquisition 12
Grindeks Completes Acquisition of HBM Pharma from Dashdirect for USD24.7 Million 12
Grindeks – Key Competitors 13
Grindeks – Key Employees 14
Grindeks – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Financial Announcements 17
Aug 30, 2018: Grindeks: Financial results for the first six months of 2018 17
Aug 30, 2018: Turnover of Grindeks reaches 71.5 million euro in the first six months of 2018; profit – 6.7 million euro 18
May 31, 2018: On “Grindeks” results in the first three months of 2018 19
May 07, 2018: Turnover of “Grindeks” reaches 132.4 million euro in 2017; profit – 10.0 million euro 20
Feb 28, 2018: Turnover of Grindeks reaches 132.4 million euro in 2017; profit – 10.3 million euro 21
Nov 27, 2017: On Grindeks results in the first nine months of 2017 22
Aug 28, 2017: Grindeks results in the first half-year of 2017 23
May 29, 2017: On “Grindeks” results in the first three months of 2017 24
Feb 28, 2017: Grindeks Announces results in 2016 25
Corporate Communications 26
Jan 09, 2018: Juris Bundulis re-elected as the Chairman of the Board; Ph.D. Juris Hmelnickis to become a Board Member of JSC Grindeks 26
Mar 01, 2017: Grindeks Announces the Board Change 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Grindeks, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Grindeks, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Grindeks, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Grindeks, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Grindeks, Deals By Therapy Area, 2012 to YTD 2018 8
Grindeks, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AB.LV Private Equity Fund Acquires Stake In Grindeks From East Capital 10
Riga Stradins University to Enter into Agreement with Grindeks 11
Grindeks Completes Acquisition of HBM Pharma from Dashdirect for USD24.7 Million 12
Grindeks, Key Competitors 13
Grindeks, Key Employees 14
Grindeks, Subsidiaries 15

List of Figures
Grindeks, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Grindeks, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Grindeks, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Grindeks, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Grindeks, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Grindeks, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Grindeks, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Grindeks, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Grindeks (GRD1R):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Malaysia Airlines Berhad:企業の戦略・SWOT・財務情報
    Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report Summary Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • C. Uyemura & Co., Ltd. (4966):企業の財務・戦略的SWOT分析
    C. Uyemura & Co., Ltd. (4966) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, PMX, SAMI, toraymyxin and reagents. Its EAA is an endotoxin activity assay, which …
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Domino’S Pizza Group Plc:企業の戦略・SWOT・財務分析
    Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report Summary Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Pharm-Olam International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization that offers clinical research services. The organization’s services include clinical trials, medical writing, medical monitoring, regulatory submissions, data management, biostatistics analysis, pharmacovigilance, …
  • ERG SpA (ERG):企業の財務・戦略的SWOT分析
    ERG SpA (ERG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Benihana Inc.:企業の戦略・SWOT・財務分析
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Metalloinvest MC LLC:企業の戦略的SWOT分析
    Metalloinvest MC LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Aero Simulation, Inc.:企業の戦略・SWOT・財務情報
    Aero Simulation, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Simulation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eneco Holding NV-エネルギー分野:企業M&A・提携分析
    Summary Eneco Holding N.V. (Eneco) is an integrated energy company. It produces, trades, transmits and supplies gas, electricity and heat. Eneco undertakes the sale, rental, installation, and maintenance of heating and hot water equipment; and maintenance of the electricity, gas and district heat ne …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析
    Summary Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses i …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • James Cropper PLC (CRPR):企業の財務・戦略的SWOT分析
    James Cropper PLC (CRPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務分析
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Zeta Petroleum Plc (ZTA):企業の財務・戦略的SWOT分析
    Summary Zeta Petroleum Plc (Zeta) is an oil and gas exploration and production company. The company explores, develops and produces natural gas and crude oil. It also owns and operates oil and gas assets such as Bobocu Gas Field, Suceava Concession, Jimbolia Oil Field, and Grivita Nord Oil Field. Ze …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆